Brain-Gut-Microbiota Axis in Alzheimer’s Disease
By K. Kowalski, A. Mulak. Journal of Neurogastroenterology and Motility, 2019
715 citations recorded by the source corpus.
Disturbances along the brain-gut-microbiota axis may significantly contribute to the pathogenesis of neurodegenerative disorders. Alzheimer’s disease (AD) is the most frequent cause of dementia characterized by a progressive decline in cognitive function associated with the formation of amyloid beta (Aβ) plaques and neurofibrillary tangles. Alterations in the gut microbiota composition induce increased permeability of the gut barrier and immune activation leading to systemic inflammation, which in turn may impair the blood-brain barrier and promote neuroinflammation, neural injury, and ultimately neurodegeneration. Recently, Aβ has also been recognized as an antimicrobial peptide participating in the innate immune response. However, in the dysregulated state, Aβ may reveal harmful properties. Importantly, bacterial amyloids through molecular mimicry may elicit cross-seeding of misfolding and induce microglial priming. The Aβ seeding and propagation may occur at different levels of the brain-gut-microbiota axis. The potential mechanisms of amyloid spreading include neuron-to-neuron or distal neuron spreading, direct blood-brain barrier crossing or via other cells as astrocytes, fibroblasts, microglia, and immune system cells. A growing body of experimental and clinical data confirms a key role of gut dysbiosis and gut microbiota-host interactions in neurodegeneration. The convergence of gut-derived inflammatory response together with aging and poor diet in the elderly contribute to the pathogenesis of AD. Modification of the gut microbiota composition by food-based therapy or by probiotic supplementation may create new preventive and therapeutic options in AD.
Subfields: Biological Psychiatry, Molecular Biology, Physiology
View Paper: https://www.semanticscholar.org/paper/c97b72eaa72a1f7af152b205f886ac883aa9fd23
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- L. Dou
- Mingjing Yan
- Jian Li
- Jun Guo
- Xiuqing Huang
- Weiqing Tang
- Tao Shen
Citations in the corpus
- Aging and aging-related diseases: from molecular mechanisms to interventions and treatments (2022, background): “Disturbance along the GBA contributes to aging-related diseases.(191) For instance, alterations in the gut microbiota composition enhance gut barrier permeability and systemic inflammation due to immune disorder, which then weakens the blood‒brain barrier (BBB) and induces neuroinflammation and ulti”